biostudies-literatureGao Jthe Innovation team foundation of fuzhou general hospital1069https://www.ebi.ac.uk/biostudies/studies/S-EPMC6839152biostudies-literatureUnknown19(1)<h4>Background</h4>The single-nucleotide polymorphism SLC39A6 rs1050631 is strongly implicated in esophageal squamous cell carcinoma, leading us to question whether it may also play a role in gastric adenocarcima (GA).<h4>Methods</h4>We genotyped the SLC39A6 rs1050631 in 512 patients who underwent GA resection. All study subjects lived in an area of China with high GA incidence. Genotypes were examined for possible correlation with survival and recurrence. The potential involvement of SLC39A6 in gastric cancer was explored in clinical samples and cell culture studies.<h4>Results</h4>Multivariable analysis showed that patients with the CT + TT genotype at SLC39A6 rs1050631 were at greater risk of recurrence (hazard ratio, HR 1.387, p = 0.004) and death (HR 1.429, p = 0.002) than patients wiBMC cancerInvolvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection.PMC68391522014CXTD04Ren WZhuang MGao JWang HHuang QWang LWeng PFang XZhang ZDang YChen SXiao CLin LfalseInvolvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection.<h4>Background</h4>The single-nucleotide polymorphism SLC39A6 rs1050631 is strongly implicated in esophageal squamous cell carcinoma, leading us to question whether it may also play a role in gastric adenocarcima (GA).<h4>Methods</h4>We genotyped the SLC39A6 rs1050631 in 512 patients who underwent GA resection. All study subjects lived in an area of China with high GA incidence. Genotypes were examined for possible correlation with survival and recurrence. The potential involvement of SLC39A6 in gastric cancer was explored in clinical samples and cell culture studies.<h4>Results</h4>Multivariable analysis showed that patients with the CT + TT genotype at SLC39A6 rs1050631 were at greater risk of recurrence (hazard ratio, HR 1.387, p = 0.004) and death (HR 1.429, p = 0.002) than patients wi2019-01-01T00:00:00Z2019 Nov2026-05-04T21:50:08.241Z2020-05-21T18:22:46ZS-EPMC68391523170363510.1186/s12885-019-6222-z